<DOC>
	<DOCNO>NCT00752115</DOCNO>
	<brief_summary>A comparison combination chemotherapy sildenafil plus carboplatin weekly taxol carboplatin weekly taxol patient previously untreated advanced non-small cell lung cancer . The study hypothesis sildenafil may improve distribution efficacy cytotoxic anticancer agent .</brief_summary>
	<brief_title>Combination Chemotherapy With Sildenafil Plus Carboplatin Paclitaxel Patients With Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Sildenafil one selective phosphodiesterase type 5 inhibitor . It use block degradative action phosphodiesterase type 5 cyclic GMP smooth muscle cell line blood vessel , lead smooth muscle relaxation blood vessel increase blood flow . Because phosphodiesterase type 5 also present arterial wall smooth muscle within lung , phosphodiesterase type 5 inhibitor also use treatment pulmonary hypertension .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Diagnosis histologically confirm stage IIIB IV nonsmall cell lung cancer Good performance status ( ECOG 01 ) No previous treatment Adequate bone marrow , liver renal function Must able swallow tablet Provided write informed consent Severe complication concomitant malignancy Contraindicated sildenafil , carboplatin taxol Inappropriate patient entry study , judge physician</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>previously untreated</keyword>
</DOC>